Solid Biosciences (SLDB) Enterprise Value (2017 - 2024)
Historic Enterprise Value for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to -$171.1 million.
- Solid Biosciences' Enterprise Value fell 1975.94% to -$171.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$171.1 million, marking a year-over-year decrease of 1975.94%. This contributed to the annual value of -$123.6 million for FY2023, which is 4214.91% up from last year.
- According to the latest figures from Q3 2024, Solid Biosciences' Enterprise Value is -$171.1 million, which was down 1975.94% from -$190.3 million recorded in Q2 2024.
- Over the past 5 years, Solid Biosciences' Enterprise Value peaked at -$24.8 million during Q3 2020, and registered a low of -$268.5 million during Q1 2021.
- Its 5-year average for Enterprise Value is -$154.7 million, with a median of -$162.9 million in 2022.
- Per our database at Business Quant, Solid Biosciences' Enterprise Value skyrocketed by 7653.2% in 2020 and then plummeted by 40104.88% in 2021.
- Quarter analysis of 5 years shows Solid Biosciences' Enterprise Value stood at -$154.7 million in 2020, then tumbled by 34.27% to -$207.8 million in 2021, then decreased by 2.86% to -$213.7 million in 2022, then surged by 42.15% to -$123.6 million in 2023, then plummeted by 38.4% to -$171.1 million in 2024.
- Its Enterprise Value was -$171.1 million in Q3 2024, compared to -$190.3 million in Q2 2024 and -$206.1 million in Q1 2024.